Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Sib 15 X 267 Gy Wbi And Sib 15 X 267312 Gy

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT01973634Phase 2CompletedPrimary

Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery.

Showing all 1 trials

Research Network

Common Treatments

  • Sib 15 X 267 Gy Wbi And Sib 15 X 267312 Gy1
  • Sequential Boost 15 X 267 Gy Wbi 6 X 248 Gy Boost1
  • Sib 15 X 267 Gy Wbi And Sib 15 X 267333 Gy1
  • Sequential Boost 15 X 267 Gy Wbi 4 X 25 Gy Boost1

Active Sponsors

  • University Hospital, Ghent1

Top Investigators

Activity Timeline